UCSF researchers have devised a CRISPR-based system called SLICE, which will allow scientists to rapidly assess the function of each and every gene in “primary” immune cells.
To develop novel therapies to treat specific subtypes of COPD, and potentially even to reverse some of the symptoms, scientists at UCSF are taking a precision medicine approach to the disease.
The ascendancy of CRISPR systems raises a grand hope: If these tools can illuminate the causes of disease in the laboratory, why not bring them into the clinic to treat patients?
A new blood test for children with brain tumors offers a safer approach than surgical biopsies and may allow doctors to measure the effectiveness of treatment even before changes are identified on scans.
A new spinal cord injury protocol, based on research by UCSF scientists, is a mixture of revised evaluations and new treatments to personalize care. It has spurred quicker recoveries for patients.
By creating a tailored drug cocktail that matches the mutations of a brain tumor, a new precision medicine approach may move the needle for children with high-grade gliomas.
UCSF researchers found that 58 percent of women who resided in a nursing home for more than 90 days before breast cancer surgery experienced significant functional decline one year after surgery.
Health professionals should recommend against parents using direct-to-consumer genetic sequencing to diagnose or screen their newborns.
Sensory Processing Disorder, or SPD, causes some children to find everyday stimuli excruciating. Scientists are finally shedding light on what causes the disorder and what can be done about it.
The journey from discovering and developing effective, precise medications to using them correctly and safely in patients is hardly fast and easy. Nor is it a straight shot. Scientists in the UCSF School of Pharmacy are challenging the status quo every step of the way.